Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer | |
Cheng, Songtao; Wang, Gang; Wang, Yejinpeng; Cai, Liwei; Qin, Kaiyu; Ju, Lingao; Liu, Xuefeng; Xiao, Yu; Wang, Xinghuan | |
刊名 | CLINICAL SCIENCE
![]() |
2019 | |
卷号 | 133期号:15 |
ISSN号 | 0143-5221 |
DOI | 10.1042/CS20190587 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4263174 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Cheng, Songtao,Wang, Gang,Wang, Yejinpeng,et al. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer[J]. CLINICAL SCIENCE,2019,133(15). |
APA | Cheng, Songtao.,Wang, Gang.,Wang, Yejinpeng.,Cai, Liwei.,Qin, Kaiyu.,...&Wang, Xinghuan.(2019).Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer.CLINICAL SCIENCE,133(15). |
MLA | Cheng, Songtao,et al."Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer".CLINICAL SCIENCE 133.15(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论